Breast cancer claims younger black female lives. If so, when should the screening begin?

Published Date: 26 Apr 2023

Once a woman turns 40, experts advise that she at the very least think about starting a breast cancer screening program. According to a recent study, Black women need this advice above all others.

Read Full News

Latest News

Look Once, Think Twice: The Art of Neurologic Diagnosis

Many neurologic conditions hide behind subtle signs, and neurophobia can further confound the diagnosis. A neurologists provides tips on when to pause and think again.

Beta-Blocker Use After Myocardial Infarction: When to Stop?

New trial data question routine long term beta blocker use after myocardial infarction in stable patients with preserved function, prompting reassessment of continuation decisions.

Ready or Not, LLMs Are Coming for Medicine

Current chatbots might show deficiencies in clinical reasoning for now, but don’t hold your breath.

SGO 2026

Read clinically focused news coverage of key developments from SGO 2026

Apr 10 2026 This Week in Cardiology

Three imaging-guided PCI trials (two with surprising results), LDL targets, an oral PCSK9 inhibitor, and another beta-blocker withdrawal trial are the topics John Mandrola, MD, discusses in this week’s podcast.

When Binge Eating Becomes an Emergency

A single binge episode may precipitate acute gastric dilatation, a rare but life-threatening condition that clinicians can easily miss.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Latest News

Many neurologic conditions hide behind subtle signs, and neurophobia can further confound the diagnosis. A neurologists provides tips on when to pause and think again.

New trial data question routine long term beta blocker use after myocardial infarction in stable patients with preserved function, prompting reassessment of continuation decisions.

Current chatbots might show deficiencies in clinical reasoning for now, but don’t hold your breath.

Read clinically focused news coverage of key developments from SGO 2026

Three imaging-guided PCI trials (two with surprising results), LDL targets, an oral PCSK9 inhibitor, and another beta-blocker withdrawal trial are the topics John Mandrola, MD, discusses in this week’s podcast.

A single binge episode may precipitate acute gastric dilatation, a rare but life-threatening condition that clinicians can easily miss.

News All Time

Bannwarth Syndrome in a Woman With Early Breast Cancer

The case emphasizes Bannwarth syndrome as a rare but treatable cause of neurologic deterioration in an older woman receiving surgical cancer care.

Can Large Language Models Simplify Radiology Reports?

A meta-analysis suggests that large language model-simplified radiology reports improve patient understanding and readability while preserving high accuracy and completeness.

NPH: What You Learned in Med School Is Wrong

Neurologists Indu Subramanian and Alfonso Fasano discuss normal pressure hydrocephalus and why some of the classic dogma about this condition is wrong.

Promoting Whole-Body Imaging: Not There Yet

Ethicist Art Caplan discusses marketing promotions for expensive whole-body imaging.

Medicine Will Turn Cellular Age Backward by 2050: Barzilai

Aging may not be permanent. Nir Barzilai explains how human cells reset to zero and why partial rejuvenation could be possible within decades.

Adding to the Toolbox: Thyroid Artery Embolization

Drs Kaniksha Desai and Juan Camacho discuss thyroid artery embolization.

The Time Burden of Cancer Treatment

Dr Kathy Miller discusses a recent study quantifying the hidden time burden of cancer care and its impact on clinic operations and patient experience.

ASCO GI: Updates in Pancreatic, Gastric, CRC

Dr Emil Lou highlights practice-changing updates from ASCO GI, including new immunotherapy, targeted therapy, and circulating tumor DNA advances across gastrointestinal cancers.

High-speed imaging tracks live brain cell activity in awake mice

A research team from the School of Engineering at The Hong Kong University of Science and Technology (HKUST) has achieved a breakthrough in brain imaging by developing the world's first technology to capture high-resolution ...

Study highlights AI limits in heart care

There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at Cedars-Sinai published in the Journal of the American Society of Echocardiography.

New material may outperform current agents used in medical imaging

Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic to patients and more environmentally ...

Imaging technique maps the brain's nerve fiber labyrinth with micrometer precision

In order to understand brain diseases, neuroscientists try to untangle the intricate nerve fiber labyrinth of our brain. Before analyzing brain tissue under a microscope, it is often soaked in paraffin wax to achieve high-quality ...

New brain atlas offers unprecedented detail in MRI scans

A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging.

Holographic optogenetics could enable faster brain mapping for new discoveries

Recent technological advances have opened new possibilities for neuroscience research, allowing researchers to map the brain's structure and synaptic connectivity (i.e., the junctions via which neurons communicate with each ...

New method noninvasively measures Achilles tendon structure and function in professional dancers

A study in the Journal of Orthopaedic Research uses a noninvasive, nonradioactive imaging-based method to measure the structure and function of the Achilles tendon in professional ballet dancers. The method could potentially ...

MRI-based evaluation system accurately quantifies paraspinal muscle atrophy and nerve root injury severity

A noninvasive MRI technique that measures volumetric changes in paraspinal muscles could transform how doctors assess nerve damage in the cervical spine, which helps guide more precise treatment decisions and potentially ...

Recommended News For You

EVP Beats Cisplatin for Resectable MIBC

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancer

CAR-T for Chronic Lymphocytic Leukemia Receives FDA Approval.

Extracellular matrix pathway emerges as treatment target for pediatric cancer

Recommended Articles For You

Exploring the Latest Treatments for Desmoid Tumors 

The Truth About Marijuana and Its Effect on Mental Health  

Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines 

Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How AI will transform mental health support for patients with breast cancer

2.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

3.

PET-CT is better than contrast-enhanced CT as a predictor of survival in patients with metastatic breast cancer

4.

Routine MRI scans detect cancers in asymptomatic patients with rare genetic condition

5.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

1.

Tazemetostat: A Promising New Treatment for Cancer

2.

Unlocking the Secrets of Oral Cancer Staging: A New Approach to Early Detection

3.

Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results

4.

Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options 

5.

The Latest Causes and Symptoms of Bowen's Disease: All You Need to Know 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

5.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot